SIBIONICS GS1 CGM, Mauritius
Know your glucose, in real time.
SIBIONICS Mauritius is a local GS1 continuous glucose monitor information site, with source-checked product education and a route to confirm current availability.
Up to 14 days
A new sensor reading is sent every 5 minutes after warm-up, within the current product instructions.
No routine calibration
The GS1 is factory calibrated. Use a blood glucose test when readings do not match how you feel, as the IFU directs.
Compatible phone app
See readings, trends, and reports in the SIBIONICS app. Check the current device compatibility list first.
Designed for daily wear
A single-use upper-arm sensor with water resistance only within the limits in your country-specific IFU.
Learn your curve
A CGM is only as useful as your ability to read it
Three short interactive guides that teach the concepts every wearer needs. Free, in your browser, nothing stored or sent.
About
What is SIBIONICS?
SIBIONICS Mauritius is a local product-information site for the SIBIONICS GS1 continuous glucose monitoring system, published within the Medtech and Chemtech Group network. It is not the manufacturer's global website. The GS1 is an upper-arm sensor that measures glucose in interstitial fluid and sends a new reading to the SIBIONICS smartphone app every 5 minutes after a 1-hour warm-up. Official product information describes up to 14 days of wear and factory calibration, so routine fingerstick calibration is not required. A blood glucose test is still required when a sensor reading does not match how you feel, as the current Instructions For Use explain. Country-specific age indications, compatible phones, water-resistance limits, and other labeling details can vary, so the product insert supplied locally is the authority. The app can display readings, trend arrows, alerts, and reports that help a person with diabetes and their care team review patterns. This site explains those concepts without interpreting personal readings or giving treatment or dosing advice. Use the contact route to ask the local team about current availability, and involve a qualified clinician when deciding whether and how to use CGM data.
Questions
Frequently asked questions
What is a continuous glucose monitor (CGM)?
A continuous glucose monitor is a wearable sensor that measures glucose in interstitial fluid just under the skin. Instead of a single meter snapshot, it builds a curve in an app and shows recent direction of change. The data can support pattern review with a diabetes care team, but it is not a diagnosis or an instruction to change treatment.
How does the Sibionics GS1 work?
The GS1 is applied to the back of the upper arm and is designed for up to 14 days of wear. After a 1-hour warm-up, it sends a new interstitial-glucose reading to the SIBIONICS app every 5 minutes. It is factory calibrated, but the official guidance still says to use a blood glucose test when readings seem wrong or do not match how you feel.
Who can benefit from using a CGM?
The GS1 is a medical device for people with diabetes, but approved ages and indications differ by country. Check the local product insert and ask a qualified clinician whether the device is appropriate for you. This site does not extend the labeled indication to general wellness use.
Does a CGM replace visits to my doctor or laboratory tests?
No. A CGM is a monitoring tool, not a diagnostic service, and it does not replace medical consultations or the laboratory tests your doctor orders, such as HbA1c. Its value is in the day-to-day detail it adds between appointments, which can make conversations with your healthcare team more concrete. Always discuss significant readings or treatment changes with your doctor.
How can I get the Sibionics GS1 in Mauritius?
Medtech lists SIBIONICS in its Mauritius brand portfolio and routes consumer product enquiries through Medshop. Use the contact page to ask the local team to confirm current stock, compatible device versions, and the right next step. Availability is not guaranteed by this page.
Latest articles
From the blog
Clearer glucose context supports better care conversations.
SIBIONICS is published within the local Medtech network. The SIBIONICS GS series is distributed in Mauritius through Medtech, with consumer devices available via the Medshop.